AMTZ LTD Celebrates a Decade of Transforming Healthcare Innovation and Indigenous Manufacturing

Date:

Share post:

AMTZ LTD marks a historic milestone as it completes 10 remarkable years of pioneering innovation, manufacturing excellence, and high-impact healthcare solutions. Over the past decade, AMTZ has evolved into a cornerstone of India’s medical technology landscape, empowering homegrown technologies and significantly reducing reliance on imported medical equipment.

Established as a world-class, 270-acre dedicated MedTech ecosystem in Visakhapatnam, AMTZ LTD has redefined medical equipment manufacturing in the region. By offering state-of-the-art common scientific testing, prototyping, and manufacturing facilities under one roof, the zone has dramatically lowered entry barriers for innovators, nurturing over 100 healthtech startups and housing specialized hubs such as the BioValley Incubation Council and the Kalam Institute of Health Technology.

Beyond empowering local entrepreneurs, AMTZ played a crucial national role during critical health crises by rapidly scaling the indigenous production of RT-PCR kits, ventilators, oxygen concentrators, and other life-saving equipment. Today, through strategic global collaborations and international trade partnerships, AMTZ continues to bring Indian biomedical innovations to the global stage.

“Reaching our 10-year milestone is a testament to the dedication of our entire ecosystem,” said an AMTZ spokesperson. “As we look ahead, AMTZ LTD enters its second decade with renewed purpose—continuing to push the boundaries of MedTech innovation, empower indigenous technologies, and shape a healthier, self-reliant future for India and the world.”

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

ViiV Healthcare Advances HIV Care with Breakthrough Long-Acting Injectable Data at AIDS 2026

ViiV Healthcare, the global specialist HIV company majority-owned by GSK plc, announced landmark clinical, real-world, and pipeline data...

Wockhardt Launches “Wockhardt Antibiotic Academy” to Tackle Growing Threat of Multidrug Resistance in India

Wockhardt Limited announced the launch of the Wockhardt Antibiotic Academy, a national initiative dedicated to fostering patient-centric scientific dialogue...

Optimus Pharma Secures Regulatory Approval for Non-Steroidal Tapinarof Cream to Treat Plaque Psoriasis

Optimus Pharma, a leading Indian pharmaceutical manufacturer and subsidiary of Sekhmet Pharmaventures, announced that it has received regulatory...

Enhertu Shows Better Results Than Standard Treatment in Lung Cancer Trial

AstraZeneca and Daiichi Sankyo announced that their antibody-drug conjugate Enhertu (trastuzumabderuxtecan) has achieved a statistically significant and clinically meaningful improvement...